🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
11.07
+0.04 (0.36%)
Nov 20, 2026, 4:00 PM EST - Market closed

MLTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9429413,4153,620409-
Market Cap Growth
-2.51%-72.45%-5.66%784.47%--
Enterprise Value
5456382,9323,189353-
Last Close Price
11.0713.1854.1560.3910.509.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.473.097.537.055.95-
P/TBV Ratio
2.473.097.647.308.37-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.270.250.010.010.00-1.29
Net Debt / Equity Ratio
-1.04-1.04-0.98-0.99-1.04-0.60
Net Debt / EBITDA Ratio
1.451.313.149.441.11-0.20
Net Debt / FCF Ratio
1.631.623.8011.781.29-0.16
Quick Ratio
8.538.7720.0751.389.440.39
Current Ratio
9.139.2721.1151.599.980.46
Return on Equity (ROE)
-81.47%-60.78%-25.08%-15.14%-225.86%-
Return on Assets (ROA)
-57.27%-50.38%-23.68%-11.94%-115.51%-664.83%
Return on Capital Employed (ROCE)
-57.40%-64.60%-31.40%-10.50%-94.00%300.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-33.08%-24.16%-3.48%-1.00%-12.21%-
FCF Yield
-25.90%-20.84%-3.43%-1.19%-13.66%-
Buyback Yield / Dilution
-18.08%-2.54%-27.99%-67.30%-274.47%-
SEC Filings: 10-K · 10-Q